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Abstract:
Daylight photodynamic therapy (DPDT) is an effective and patient preferred treatment for the management of 
field change actinic keratosis. An important factor in DPDT is light dosimetry, to ensure that patients receive 
sufficient daylight for effective treatment, and this is the focus of the contribution to this issue by La Rochelle 
et al.(Photochem. Photobiol., 2019, https://doi.org/10.1111/php.13170). In this work, the authors present an 
easy to use method for obtaining real-time information about patient received light dose during treatment, and 
for determining indoor locations best suited to DPDT.
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This issue of Photochemistry and Photobiology contains a study by La Rochelle et al. [1] concerning daylight 
photodynamic therapy (DPDT), which has become a popular treatment in Europe for actinic keratoses (AK) 
since it was first reported on in 2008 [2]. DPDT offers comparative clearance rates to conventional 
photodynamic therapy (PDT) for treating field-cancerised areas such as the face and scalp, while causing 
minimal pain.
Whereas light dose in conventional PDT can be closely controlled, in DPDT light dose is dependent on the 
outdoor conditions over the duration of treatment. This understandably makes practitioners wary about 
prescribing DPDT. The literature suggests that there is a minimum effective PpIX-weighted dose of light that a 
patient should receive over a 2-hour treatment to maximise outcomes – below this dose, efficacy falls and 
above it there is no benefit [3]–[5]. Understanding the dose of light that a patient has been exposed to during 
DPDT is therefore critical [6], with efforts focused on improving dosimetry to give the user greater confidence 
in treatment outcome and patient satisfaction.
However, light availability is not the only concern, general weather conditions; rain, wind, temperature etc, may 
also limit treatment [5]. Indoor DPDT through window glass has therefore become a consideration, protecting 
the patient from adverse weather conditions and negating the need for sunscreen by attenuating much of the 
erythemally effective UV radiation [7]. Window glass does however also attenuate useful UVA and visible light 
[1], [7], [8]. As such dosimetry is of even greater importance in indoor DPDT, to ensure that patients receive an 
adequate light dose during treatment.
La Rochelle et al., propose a single site analysis alongside automatic data processing from local weather 
monitoring stations to obtain real-time light dosimetry of DPDT. One of the obvious advantages to such a 
method is that, other than the one-time site assessment, no specialist equipment is required for day-to-day 
patient dose assessment in clinic. Thus, there is the potential to streamline indoor DPDT and provide a greater 
level of confidence to both practitioner and patient. A flowchart in Figure 1 illustrates the proposed workflow 
for the method.
<Figure 1>
To test the method of La Rochelle et al. data from the nearest weather station to our location (Ninewells 
Hospital, Dundee, 56.46° N, 2.97° W) was obtained. At 12:30 UTC (Coordinated Universal Time), on the 11th 
of October 2019 the weather station provided a cloud-adjusted daylight irradiance in the horizontal plane of 
402.65 W m-2 and a UV index of 3.55. Using Figure 5 from La Rochelle et al, PpIX-weighted irradiances of 6.33 
W m-2 and 3.69 W m-2 are determined from the cloud-adjusted daylight irradiance and UV index respectively. 
These values we compared to our own independent measurement (380–800 nm, WaveGo, Ocean Optics, 
USA) made inside a window in a southerly facing office at Ninewells Hospital. Our measurement result was a 
PpIX-weighted irradiance of 5.64 W m-2. La Rochelle et al. predicted values were 12% higher (daylight A
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irradiance) and 34% lower (UV Index) than our measured value and fall within the authors stated 95% 
prediction limits (Figure 2).
<Figure 2>
The cloud-adjusted daylight metric was the most accurate in our example and the resulting predicted PpIX-
weighted dose is 4.56 J cm-2. This assumes a 2-hour treatment duration but is based on only a single 
measurement. According to the latest literature, this value verges on what may be considered the minimum 
dose threshold for effective treatment [5]. Having this knowledge in real-time, made possible by the model of 
La Rochelle et al. allows dose adjustment by the clinician through variation of the exposure time.
In addition, spectral irradiance measurements from the one-time setup described by La Rochelle et al. can be 
used to provide information on the minimum treatment time by depth in tissue [9]. The authors propose that 
sufficient PpIX-weighted daylight doses could be achieved in under the recommended treatment time of 2 
hours. For example, from our measurement the La Rochelle et al. model indicates minimum treatment times of 
3, 27 and 107 minutes at depths of 0.5, 1 and 1.5 mm respectively. It must be noted that these are currently 
theoretical values, there is as yet no clinically supported evidence showing that treatment times shorter than 1.5 
hours [10] in DPDT will lead to equivalent outcomes - even if the minimum threshold light dose is met. 
Historically, dosimetry methods in DPDT have focused on surface irradiance measurements, therefore it 
remains to be seen how clinically useful the dose at depth information might be on a day-to-day basis. 
However, with this information now readily available, perhaps the link between depth-dependent dose and 
lesion clearance in DPDT could be elucidated.
We found the determination of PpIX-weighted irradiance using this technique very easy and were pleasantly 
surprised that the result was within the accepted confidence intervals, particularly as our measurement was 
performed over 3000 miles from the location of the original research. Convenience and confidence are key in 
the uptake of any new technology or treatment in clinic. If, as the authors propose, the method described here 
is packaged into an easy to use software application, it could become a useful tool in supporting the uptake of 
indoor DPDT. Most centres, in our opinion, would be willing to undergo the one-time setup process in order 
to facilitate a robust indoor DPDT service. In conclusion, the authors propose and demonstrate a workable 
solution to increasing uptake of this important treatment by providing crucial information to the prescribing 
clinician.
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FIGURE CAPTIONS
Figure 1. Flowchart illustrating the proposed workflow for this DPDT dosimetry method. The 
‘during treatment’ section is planned to be integrated into a user-friendly, automated application, 
which would maximise the accessibility of this method.
Figure 2. Reproduced from La Rochelle et al. [1], cloud adjusted sunlight and UV index from weather 
data are plotted against measured PpIX-weighted irradiance (red crosses) for our single measurement. 
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